A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease

被引:79
作者
Cheng, Alan
Zhang, Mei
Gentry, Matthew S.
Worby, Carolyn A.
Dixon, Jack E.
Saltiel, Alan R. [1 ]
机构
[1] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Physiol, Inst Life Sci, Ann Arbor, MI 48109 USA
[3] Univ Calif San Diego, Sch Med, Dept Pharmacol, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
关键词
glycogen debranching enzyme; Lafora disease; Cori's disease; ubiquitination; malin;
D O I
10.1101/gad.1553207
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cori's disease is a glycogen storage disorder characterized by a deficiency in the glycogen debranching enzyme, amylo-1,6-glucosidase,4-alpha-glucanotransferase (AGL). Here, we demonstrate that the G1448R genetic variant of AGL is unable to bind to glycogen and displays decreased stability that is rescued by proteasomal inhibition. AGL G1448R is more highly ubiquitinated than its wild-type counterpart and forms aggresomes upon proteasome impairment. Furthermore, the E3 ubiquitin ligase Malin interacts with and promotes the ubiquitination of AGL. Malin is known to be mutated in Lafora disease, an autosomal recessive disorder clinically characterized by the accumulation of polyglucosan bodies resembling poorly branched glycogen. Transfection studies in HepG2 cells demonstrate that AGL is cytoplasmic whereas Malin is predominately nuclear. However, after depletion of glycogen stores for 4 h, similar to 90% of transfected cells exhibit partial nuclear staining for AGL. Furthermore, stimulation of cells with agents that elevate cAMP increases Malin levels and Malin/AGL complex formation. Refeeding mice for 2 h after an overnight fast causes a reduction in hepatic AGL levels by 48%. Taken together, these results indicate that binding to glycogen crucially regulates the stability of AGL and, further, that its ubiquitination may play an important role in the pathophysiology of both Lafora and Cori's disease.
引用
收藏
页码:2399 / 2409
页数:11
相关论文
共 37 条
  • [1] The role of protein phosphatase-1 in insulin action
    Brady, MJ
    Saltiel, AR
    [J]. RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 157 - 173
  • [2] Chan Elayne M, 2005, Adv Neurol, V95, P47
  • [3] Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy
    Chan, EM
    Ackerley, CA
    Lohi, H
    Ianzano, L
    Cortez, MA
    Shannon, P
    Scherer, SW
    Minassian, BA
    [J]. HUMAN MOLECULAR GENETICS, 2004, 13 (11) : 1117 - 1129
  • [4] Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II)
    Chandran, P
    Safthaporn, S
    Robins, A
    Eremin, O
    [J]. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2003, 1 (03): : 125 - 136
  • [5] PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance
    Crosson, SM
    Khan, A
    Printen, J
    Pessin, JE
    Saltiel, AR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) : 1423 - 1432
  • [6] Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation
    Fernández-Sánchez, ME
    Criado-García, O
    Heath, KE
    García-Fojeda, B
    Medraño-Fernández, I
    Gomez-Garre, P
    Sanz, P
    Serratosa, JM
    de Córdoba, SR
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (23) : 3161 - 3171
  • [7] Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes
    Ganesh, S
    Agarwala, KL
    Ueda, K
    Akagi, T
    Shoda, K
    Usui, T
    Hashikawa, T
    Osada, H
    Delgado-Escueta, AV
    Yamakawa, K
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (15) : 2251 - 2261
  • [8] Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy
    Ganesh, S
    Puri, R
    Singh, S
    Mittal, S
    Dubey, D
    [J]. JOURNAL OF HUMAN GENETICS, 2006, 51 (01) : 1 - 8
  • [9] The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies
    Ganesh, S
    Tsurutani, N
    Suzuki, T
    Hoshii, Y
    Ishihara, T
    Delgado-Escueta, AV
    Yamakawa, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (04) : 1101 - 1109
  • [10] Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice
    Ganesh, S
    Delgado-Escueta, AV
    Sakamoto, T
    Avila, MR
    Machado-Salas, J
    Hoshii, Y
    Akagi, T
    Gomi, H
    Suzuki, T
    Amano, K
    Agarwala, KL
    Hasegawa, Y
    Bai, DS
    Ishihara, T
    Hashikawa, T
    Itohara, S
    Cornford, EM
    Niki, H
    Yamakawa, K
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (11) : 1251 - 1262